NASDAQ:EVAX
Evaxion Biotech A/S
- Stock
locale
Denmarkmarket
STOCKSindustry
Biotechnologywebsite
www.evaxion-biotech.comipo date
Feb 05, 2021
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melano...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus